TARGETING HEPATOCYTE RECEPTOR TYROSINE KINASES BY ERLOTINIB AND INHIBITION OF HEPATITIS C VIRUS INFECTION IN VIVO
Lupberger J., Zeisel MB., Xiao F., Thumann C., Mee CJ., Davis C., McKeating JA., Fofana I., Soulier E., Zona L., Lavillette D., Cosset F-L., Patel AH., Doffoel M., Baumert TF.